Arrowhead Pharmaceuticals Inc (ARWR)

Add to Watchlists
Create an Alert
35.95 -0.65  -1.78% NASDAQ Oct 18, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
12/11/2019 16:30 EST Misc Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2019
12/11/2019 Earnings Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings in 2019 Release
08/05/2019 16:30 EDT Misc Arrowhead Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2019
08/05/2019 Earnings Arrowhead Pharmaceuticals Inc Third Quarter Earnings in 2019 Release
05/08/2019 16:30 EDT Misc Arrowhead Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2019
05/08/2019 Earnings Arrowhead Pharmaceuticals Inc Second Quarter Earnings in 2019 Release
03/14/2019 10:00 PDT Misc Arrowhead Pharmaceuticals Inc Annual General Meeting in 2018
02/07/2019 16:30 EST Misc Arrowhead Pharmaceuticals Inc First Quarter Earnings Conference Call in 2019
02/07/2019 Earnings Arrowhead Pharmaceuticals Inc First Quarter Earnings in 2019 Release
12/11/2018 16:30 EST Misc Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.arrowheadpharma.com
  • Investor Relations URL: http://ir.arrowheadpharma.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Dec. 11, 2019
  • Last Earnings Release: Aug. 05, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Top Fund Holders

Symbol Name Weighting
PSCH Invesco S&P SmallCap Health Care ETF 3.78%
PBE Invesco Dynamic Biotech & Genome ETF 2.92%
FMLYGX FT Sabrient Small Cap Growth 23 RE 2.84%
XBI SPDR® S&P Biotech ETF 1.93%
GOFFX Invesco Oppenheimer Global Opp R5 1.87%
CPNFX Invesco All Cap Market Neutral R5 1.73%
IJT iShares S&P Small-Cap 600 Growth ETF 0.91%
SLYG SPDR® S&P 600 Small Cap Growth ETF 0.91%
QSSRX AQR TM Small Cap Multi-Style R6 0.79%
PSAPX Principal SmallCap S&P 600 Index R1 0.45%
IJR iShares Core S&P Small-Cap ETF 0.45%
CXXRX Columbia Small Cap Index Inst2 0.45%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.